We had a wonderful day at Saturday's Foundation Fighting Blindness Boston #VisionWalk. Thank you to all who participated in this fun event. #FightBlindness #AlkeusPharma #Stargardt #YourNorthStarg Paula Pearson, Julia Carpenter-Conlin MSW, Donna de Foleschampe, Duoxi Xian, Amnon Eylath, Nicholas Marji, Chayla Freeman, MS, JD, Tamara DillonMichel Dahan, Sara Handy, MD/MPH, James (Jay) M. Robinson, Jr., Jill D'Andrea Fischmann
关于我们
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
- 网站
-
https://www.alkeuspharma.com
Alkeus Pharmaceuticals, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Cambridge，MA
- 类型
- 私人持股
- 创立
- 2010
- 领域
- Biopharmaceuticals、Rare Disease、Inherited Retinal Disorders、Genetic Diseases、Retina和Ophthalmology
地点
-
获取路线
.
US，MA，Cambridge
Alkeus Pharmaceuticals, Inc.员工
动态
-
October is Blindness Awareness Month. All month long we will be highlighting important facts and sharing perspectives of those with vision loss. https://lnkd.in/eysfKJj #ShareYourVision #AlkeusPharma #YourNorthStarg
-
We are excited and honored to be selected as a finalist for the Biotech Week Boston Awards category of Biotech Innovation. This award recognizes a company for creating a new or advancing biopharmaceutical product, manufacturing process or ground-breaking technology that yielded significant results. We look forward to attending the event on Monday, September 23. https://lnkd.in/ehi_EvwZ #alkeuspharma #biotech #BWBawards
-
-
We were pleased to support the Lighthouse Guild's #EveningofDiscovery this week. Lighthouse Guild provides services that inspire people who are visually impaired to achieve their goals. A big thank you to Kiana Glanton and the team at Lighthouse Guild for an inspiring event.?Julia Carpenter-Conlin MSW and Paula Pearson https://lnkd.in/dgucp_BM #AlkeusPharma #Stargardt #inspired
-
-
Today we announced the topline results from our SAGA study in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Read the press release here: https://lnkd.in/eNB__ac5 #AlkeusPharma #biotech #SAGAstudy?
-
-
We're excited to share that a new video is now live on YourNorthStarg.com featuring the perspective of Christine Nichols Kay, MD, a board-certified ophthalmologist and vitreoretinal surgeon from Gainesville, FL. Dr. Kay's focus and passion are inherited retinal diseases, including Stargardt. You can view the full video here: https://lnkd.in/eHygrpDu #YourNorthStarg #Stargardt #perspectives #AlkeusPharma
-
September is National Guide Dog Month. Join us in celebrating these wonderful pups and those who train them. https://lnkd.in/gm_Vsc9N #AlkeusPharma #GuideDogMonth #YourNorthStarg
-
We're #hiring a new Vice President of Marketing based in Cambridge, MA. Apply today or share this post with your network. https://lnkd.in/eb8RJWfH
-
Approximately 50% of people diagnosed with Stargardt disease experience significant visual impairment within three years of symptom onset. Learn more at: https://lnkd.in/gZJinepx #alkeuspharma #stargardt #YourNorthStarg
-